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Abstract In Alzheimer disease (AD) brain, activities of protein
phosphatase (PP)-2A/PP-1 which are known to be associated
with microtubules are compromised and are probably a cause of
neurofibrillary degeneration through hyperphosphorylation of
microtubule proteins. In the present study, an increase of V11
pmol phosphate/Wg protein in 100 000Ug pellet from AD
compared with age-matched control brains was found. Tau
protein, which is hyperphosphorylated in AD can only account
for V4 pmol phosphate/Wg protein, suggesting the presence of
non-tau hyperphosphorylated proteins in the diseased brain.
Western blot analysis with phosphoserine antibodies revealed a
V54 kDa non-tau protein to be significantly hyperphosphory-
lated in AD compared with age-matched control cases in the
particulate fraction. The V54 kDa protein was purified by
preparative sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis and identified as L-tubulin by immunolabeling with
specific antibodies, mass spectrometry analysis and by N-
terminal amino acid sequencing. The purified protein was
hyperphosphorylated at serine residues in AD. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
In Alzheimer disease (AD) brain the neuronal cytoskeleton
is disrupted and replaced by the accumulation of paired hel-
ical ¢laments (PHF). Microtubule (MT)-associated protein
tau, the major protein subunit of PHF, is abnormally hyper-
phosphorylated and an imbalance in the protein kinase-pro-
tein phosphatase (PP) system has been implicated in this ab-
normal phosphorylation [1^5]. Furthermore, the activities of
phosphoseryl/phosphothreonyl PP-1 and -2A, which are asso-
ciated with MTs [6,7], expressed in neurons [8] and regulate
the phosphorylation of neuronal proteins at serines and threo-
nines [9^12], are decreased in AD brain [13,14]. Employing
metabolically active rat brain slices as a model system and
inhibition of PP-2A by okadaic acid, Bennecib et al. [15]
have demonstrated that a decrease in PP-2A activity leads
to the hyperphosphorylation of tau not only by a decrease
in its dephosphorylation but also by an increase in calcium-
calmodulin-dependent protein kinase II activity which is regu-
lated by this phosphatase. A recent study has reported an
increase in cyclin-dependent protein kinase-5 activity in AD
brain mediated by the conversion of a rather unstable regu-
latory subunit p35 to a relatively more stable p25, which ac-
cumulates and activates this kinase [17]. However, Taniguchi
et al. [18] have been unable to reproduce these ¢ndings. The
abnormal hyperphosphorylation of tau and changes in en-
zyme activities that regulate the intracellular protein phos-
phorylation/dephosphorylation are consistent with the hy-
pothesis that there is a general imbalance in the protein
phosphorylation/dephosphorylation system and that in addi-
tion to tau one or more phosphoproteins in the a¡ected neu-
rons might be abnormally hyperphosphorylated in AD brain.
MTs, which are required for axonal transport and thus are
critical to neuronal function, are rarely seen in neurons with
neuro¢brillary tangles [19]. The major MT protein subunit,
tubulin, is a 100^110 kDa heterodimer of K- and L-tubulin
[20]. Both of these tubulins exist in several isotypic forms,
encoded by di¡erent genes [21]. Of the various tubulin iso-
types, L-III isotype was previously shown to be phosphorylat-
ed [22^24]. Although phosphorylation of L-III-tubulin does
not a¡ect its polymerization into MTs, it inhibits the micro-
tubule-associated protein (MAP)2-promoted MT assembly,
suggesting that this post-translational modi¢cation might be
involved in the regulation of MT assembly through tubulin^
MAP interaction [25].
Here, we report the hyperphosphorylation of a 54 kDa non-
tau phosphoprotein in the 100 000Ug particulate fraction of
brain of AD patients. This V54 kDa protein, which was
found to be hyperphosphorylated at serine residues in AD
compared with age-matched controls, was puri¢ed by prepa-
rative sodium dodecyl sulfate^polyacrylamide gel electropho-
resis (SDS^PAGE) and identi¢ed as L-tubulin by immunolab-
eling with speci¢c antibodies to L-tubulin, by mass
spectrometry (MS) and by N-terminal amino acid sequenc-
ing.
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2. Materials and methods
2.1. Brain tissue
The brains of 15 AD patients with a mean age of 71.8 years ( þ 8.3
years) were employed for the present study. All the AD brains had
been histopathologically con¢rmed and contained the hallmark le-
sions speci¢c for AD, i.e. plaques and tangles. Post-mortem delays
were 4.0 þ 1.5 h. The mean age of the 13 non-AD brains used as
controls in this study was 79.4 years ( þ 4.8 years) and the post-mor-
tem delays were 4.5 þ 1.0 h. The human tissues were obtained from
the Brain Tissue Resource Center, McLean Hospital, Belmont, MA,
USA and The Netherlands Brain Bank (Dr. Rivka Ravid), The Neth-
erlands, and from our Institute for Basic Research Brain Bank (Dr.
Peter Koslowski), Staten Island, NY, USA.
2.2. Removal of non-protein phosphates
Neocortices from AD or control brains, cleaned free of meninges
and underlying white matter were homogenized at 4‡C in 0.1 M 2-[N-
morpholino]ethanesulfonic acid (MES) bu¡er, pH 5.7, 1 mM dithio-
threitol (DTT), 50 mM NaF, 1 mM Na3VO4 and 1 mM phenylmeth-
ylsulfonyl £uoride (PMSF) (1:9 w/v) using a Potter^Elvejam homog-
enizer. The homogenates were centrifuged at 100 000Ug for 30 min at
4‡C to obtain the supernatant and the pellet fractions; non-phospho-
protein phosphate was removed as described previously [26,27].
Brie£y, to an aliquot of each sample, 0.0125% Na-deoxycholate and
6% trichloracetic acid (TCA) were added to precipitate proteins. After
centrifugation in a Beckman Model GS-6R centrifuge at 2600Ug for
30 min, ether:ethanol (1:1) mixture was added to the pellet and mixed
thoroughly before centrifugation. The pellet obtained was then boiled
in 16% TCA for 20 min and centrifuged as above. The pellets were
washed with 10% TCA before resuspending in 0.1 N NaOH. Protein
was assayed by modi¢ed Lowry’s method as described by Bensadoun
and Weinstein [28] and required amounts of protein were dried in
thick-walled glass tubes using a Jouan RC 10.22 vacuum concentra-
tor, after which the dried samples were used for phosphate analysis.
2.3. Phosphate analysis
For total phosphate estimation, to the dry samples 60 Wl of 5%
MgNO3 in 95% ethanol was added. The samples were heated on a
heating block for 20 min, followed by ashing over open £ame, until
ash was formed. The ash was dissolved in 40 Wl of 1 N H2SO4,
followed by centrifugation to get rid of any precipitates that may
interfere with the assay. Then, in a microtiter plate, 25 Wl of the
supernatant/well was transferred and mixed with 50 Wl of dye mixture
(0.045% malachite green, 4.2% ammonium molybdate in 4 N HCl, 3:1
mixed with 100 Wl of 2% Tween 20). After 15 min incubation, optical
density was read at 660 nm. Non-ashed protein samples treated as
above except the ashing step were employed to determine the levels of
any free phosphate. The values for protein-bound phosphate were
calculated by subtracting the values of inorganic/free phosphate
from the total (ashed samples) phosphate [26].
2.4. Separation of phosphoproteins by iron metal a⁄nity
chromatography (IMAC)
Chelating Sepharose was packed in a column (1U4 cm; 2 ml bed
volume) and 2.5 bed volumes of 50 mM FeCl3 was passed through the
column. This was followed by extensive washing of the column with
distilled water, until the eluent became colorless. The column was then
equilibrated with 0.1 M MES, pH 5.7, containing 1 mM DTT, 50 mM
NaF, 1 mM Na3VO4, 1 mM PMSF. After loading the 100 000Ug
brain extract (see Section 2.2) on the column, the proteins were eluted
by step elution, ¢rst by using 0.1 M 3-[N-morpholino]propanesulfonic
acid, pH 7.0, containing 1 mM DTT, 50 mM NaF, 1 mM Na3VO4,
1 mM PMSF and 1 M NaCl and then by 0.1 M Tris, pH 9.0, con-
taining 1 mM DTT, 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF and
1 M NaCl. The £ow rate was 15 ml/h throughout the procedure [29].
2.5. Western blots
The 100 000Ug pellet or supernatant of the tissue homogenate was
subjected to electrophoresis on a 5^15% gradient SDS^PAGE [30].
Proteins from the gel were transferred to a polyvinylidene di£uoride
membrane. The membrane was blocked with 5% BSA^TBST (bovine
serum albumin^50 mM Tris bu¡er, pH 7.6, 0.9% NaCl, 0.05% Tween
20) and incubated with the appropriate primary antibody, followed by
incubation with 125I-labeled or horseradish peroxidase (HRP)-labeled
secondary antibody. The membranes were washed adequately with
TBST before exposing to a phosphorimager screen or developing
with enhanced chemoluminescence (ECL) reagents (1:1), followed
by exposure to Kodak X-ray ¢lm. The immunoreactivity was quanti-
tated using a phosphorimager (Fuji ¢lm BAS-1500, Japan). 125I-la-
beled anti-mouse and anti-rabbit secondary antibodies were purchased
from Amersham, Piscataway, NJ, USA. Anti-mouse and anti-rabbit
HRP-labeled secondary antibodies were from Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA. Polyclonal anti-phosphoserine (P-Ser)
antibodies were from Zymed Labs, San Francisco, CA, USA, and
monoclonal anti-L-tubulin was from Calbiochem, San Diego, CA,
USA.
2.6. Puri¢cation of the V54 kDa protein by preparative SDS^PAGE
The 100 000Ug pellet of brain homogenate was ¢rst extracted with
a mixture of detergents (1% NP-40, 0.5% sodium deoxycholate and
0.1% SDS) by incubating for 3 h at room temperature (RT) with
intermittent mixing, followed by centrifugation at 100 000Ug for 30
min at 4‡C. The detergent insoluble fraction was incubated in 6 M
guanidinium hydrochloride (GnHCl) for 3 h at RT with intermittent
mixing, followed by centrifugation as above. The GnHCl soluble
fraction was dialyzed against 2 M urea containing 50 mM Tris, pH
7.6, 25 mM NaF, 1 mM Na3VO4, 1 mM DTT, and V1 mg protein
was loaded on a 10% preparative SDS^PAGE (Model 491 Prep Cell
from Bio-Rad, CA, USA) and 288 fractions were collected at an
elution rate of 60 ml/h. Fractions containing the V54 kDa protein
were detected by monitoring all fractions by both Coomassie blue
staining as well as Western blot analyses with P-Ser antibodies
(Zymed Labs, San Francisco, CA, USA).
2.7. MS of the puri¢ed protein
The Coomassie blue-stained protein was excised from a 10% SDS^
PAGE gel, washed 25 times with distilled water, to minimize SDS
content, and dried using a vacuum concentrator. The dried gel was
hydrated in 100 Wl of 100 mM Tris, pH 8.8, followed by addition of
10 Wl of 45 mM DTT and incubation for 30 min at 55‡C. The solution
was discarded and the gel was taken up in 100 Wl of 100 mM Tris, pH
8.8, 10 Wl of 100 mM iodoacetamide, and incubated for 1 h in the
dark at RT. The gel was then washed with 500 Wl of 50 mM Tris, pH
8.8/50% acetonitrile (ACN) for 30 min, and gel-dried to completion in
a vacuum concentrator. The dried gel containing the protein was then
rehydrated in 40 Wl of 25 mM Tris, pH 7.8, and the protein in the gel
was digested with 1 pmol of LysC (su⁄cient volume to cover the gel)
overnight at 37‡C. Peptides were extracted from the gel with 50%
ACN/0.1% tri£uoroacetic acid (TFA) for 30 min at 37‡C. The extract
was removed from the gel and vacuum-concentrated to about 10 Wl.
Then, 2 Wl digested peptides were mixed with 1 Wl of matrix solution
(10 mg/ml of K-cyano-4-hydroxycinnamic acid in 0.1% TFA/33%
ACN/33% ethanol) and spotted on a matrix-assisted laser desorp-
tion/ionization (MALDI) plate in aliquots of about 1 Wl. MS-MALDI
was performed on a Perkin-Elmer Voyager DE-RP machine using
re£ector mode to obtain monoisotopic peptide masses.
2.8. N-terminal amino acid sequencing of the puri¢ed V54 kDa protein
The Coomassie blue-stained puri¢ed protein was excised from a
10% SDS^PAGE, washed and vacuum-dried as described for MS
analysis. Automated Edman sequencing for the puri¢ed V54 kDa
protein was performed using a Procise 494 ABI sequenator with re-
agents and methods of the manufacturer.
3. Results
3.1. Phosphoprotein phosphate levels in the frontal gray matter
of AD and age-matched control cases
In order to determine the general phosphorylation status of
brain proteins, the 100 000Ug pellet, 100 000Ug supernatant
and the IMAC fractions of 100 000Ug supernatant ^ un-
bound, pH 7.0 and pH 9.0 elutes of ¢ve AD and ¢ve age-
matched control cases were assayed for protein-bound phos-
phate as described in Section 2. The 100 000Ug pellet of AD
cases contained V11 pmol phosphate/Wg protein more than
the age-matched controls (Table 1), whereas the 100 000Ug
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supernatant and the three IMAC fractions from the super-
natant did not reveal any statistically signi¢cant di¡erences
between AD and age-matched control cases (Table 1).
3.2. Identi¢cation of a 54 kDa protein hyperphosphorylated in
AD brain
In order to identify hyperphosphorylated proteins, the
100 000Ug pellet, which showed increased levels of phospho-
protein phosphate in AD cases, was analyzed by Western
blots developed with antibodies that speci¢cally recognized
P-Ser, phosphothreonine or phosphotyrosine residues. At
least four polypeptides were found to be hyperphosphorylated
at serine residues in the AD frontal gray matter as compared
with the corresponding tissue from age-matched controls (Fig.
1a,b). AV54 kDa protein was V50% more hyperphosphory-
lated in AD than control brains.
While three of the four hyperphosphorylated polypeptides
were also tau immunoreactive, the V54 kDa hyperphos-
phorylated protein was found to be tau immuno-negative
(data not shown). The identity of the V54 kDa hyperphos-
phorylated protein was further pursued. No changes in phos-
phorylation at serine residues were observed in the 100 000Ug
supernatant of AD cases compared with age-matched controls
(data not shown).
3.3. Solubilization of the V54 kDa protein
A battery of detergents/denaturants were utilized to solubi-
lize the 100 000Ug pellet proteins. The hyperphosphorylated
V54 kDa non-tau protein was insoluble in 1% Triton X-100,
6% Triton X-100, 1% NP-40 and in a mixture of detergents
Table 1
Picomol of phosphate per microgram of protein in the supernatant,
the three IMAC fractions and the 100 000Ug pellet of AD and con-
trol gray matter homogenates.
Fraction AD Control
Supernatant 10.0 þ 0.8 10.4 þ 1.9
Unbound 9.9 þ 5.0 10.3 þ 4.4
pH 7.0 eluate 6.3 þ 1.4 6.7 þ 1.4
pH 9.0 eluate 19.8 þ 6.8 22.5 þ 5.8
Pellet 75.5 þ 4.7 63.9 þ 5.4
Fig. 1. Western blots of the 100 000Ug pellet of frontal gray matter
homogenates from AD and age-matched control cases developed
with antibody to P-Ser. a: The 100 000Ug pellets of gray matter ho-
mogenates from AD and age-matched control cases were electro-
phoresed (30 Wg/lane) on 5^15% SDS^PAGE and the proteins trans-
ferred to polyvinylidene di£uoride membrane. After blocking with
5% BSA^TBST, the phosphorylated serine residues of proteins were
immunodetected using polyclonal P-Ser antibodies (1:750) and
HRP-conjugated secondary antibody (1:25 000). The blots were de-
veloped by ECL reagents. Lanes 1^6: AD; lanes 7^10: age-matched
controls. The intensity of immunoreactivity was quantitated by den-
sitometry. b: P-Ser immunoreactivity was signi¢cantly higher in
V40, V54, V60 and 68 kDa polypeptides in AD compared with
age-matched controls.
Fig. 2. Extraction of the V54 kDa protein from the 100 000Ug pel-
let of brain homogenate. Results of extractions by detergents and
GnHCl as analyzed by SDS^PAGE and Western blots. Six milli-
grams of 100 000Ug pellet protein was incubated individually with
3 ml of (a) 1% Triton X-100, (b) 6% Triton X-100, (c) 1% NP-40,
(d) 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS or (e) 6 M
GnHCl for 3 h at RT with intermittent mixing before centrifugation
at 100 000Ug for 30 min at 4‡C. The supernatant (S) was consid-
ered the detergent/denaturant soluble pool of protein and the pellet
(P), the insoluble pool. Sample before centrifugation was termed ex-
tract (E). All the di¡erent pools of protein were then analyzed for
the presence of a V54 kDa protein by Western blots developed
with P-Ser antibodies (1:750). The V54 kDa protein remained in-
soluble in all the detergents used (a^d) and was soluble only in 6 M
guanidine hydrochloride (e).
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containing 1% NP-40, 0.5% sodium deoxycholate and 0.1%
SDS (Fig. 2a^d), whereas treatment of the 100 000Ug pellet
with 6 M GnHCl solubilized the V54 kDa protein (Fig. 2e).
About 60% of the 100 000Ug pellet protein was soluble in the
mixture of detergents. Further extraction of the detergent in-
soluble pellet with 6 M GnHCl yielded an enrichment of the
V54 kDa protein. The GnHCl extract which was enriched in
the V54 kDa hyperphosphorylated protein was dialyzed
against Tris bu¡er containing 2 M urea before subjecting to
puri¢cation by preparative SDS^PAGE.
3.4. Puri¢cation of the V54 kDa protein by preparative
SDS^PAGE
The V54 kDa protein-enriched preparation in 2 M urea
was subjected to 10% preparative SDS^PAGE to isolate the
V54 kDa hyperphosphorylated protein. Only two to three
fractions matched both the correct molecular size, as moni-
tored by Coomassie staining, and the intense P-Ser immuno-
reactivity pattern (note that the V54 kDa protein is a pre-
dominant P-Ser immunoreactive band in Fig. 1 as well as Fig.
3b, lane 1), as determined by Western blots with P-Ser anti-
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bodies (Fig. 3a^b). The V54 kDa hyperphosphorylated pro-
tein was excised from Coomassie blue-stained gel (Fig. 3a) for
identi¢cation by MS.
3.5. Identi¢cation of the V54 kDa hyperphosphorylated
protein as L-tubulin
The puri¢ed V54 kDa protein excised from Coomassie
blue-stained gel was digested with Lys-C before subjecting
to MS-MALDI. The spectrometric analysis revealed the iden-
ti¢cation of the V54 kDa protein as L-tubulin (accession
number X79535; Fig. 3c). The identi¢cation of the V54
kDa protein as L-tubulin was con¢rmed by Western blots
developed with antibodies to L-tubulin (Fig. 3b, lane 3). Ami-
no-terminal amino acid analysis (carried out at a sensitivity of
0.5 pmol for each amino acid residue) of the V54 kDa pro-
tein revealed a single polypeptide which matched with the
previously known amino acid sequence of L-tubulin identi¢ed
by MS-MALDI (Fig. 3d).
3.6. Preparative electrophoresis-puri¢ed L-tubulin is
hyperphosphorylated at serine residues
In order to con¢rm whether L-tubulin from AD brain was
indeed hyperphosphorylated as compared with that of age-
matched control brains, the preparative SDS^PAGE-puri¢ed
V54 kDa protein, identi¢ed as L-tubulin, was subjected to
Western blots developed with antibodies to P-Ser. The P-Ser
immunoreactivity normalized against L-tubulin immunoreac-
tivity was found to be 43% more in puri¢ed L-tubulin from
AD compared with age-matched controls, con¢rming that this
protein is hyperphosphorylated at serine residues in AD brain
(Fig. 4).
4. Discussion
Previous studies in which tau was found to be abnormally
hyperphosphorylated had hypothesized that there might be a
protein phosphorylation/dephosphorylation imbalance in AD
brain [1^4]. In the present study, we have found that the
particulate pool of L-tubulin, a non-tau protein, is also ab-
normally hyperphosphorylated in AD brains.
The level of the abnormally hyperphosphorylated tau (for
an average molecular weight of 45 000) is V0.2^0.4 pmol/Wg
100 000Ug pellet protein from AD brain [31,32], and it has a
phosphorylation stoichiometry of V6^10 mol phosphate/mol
of the protein [27]. In the present study, we found that the
100 000Ug pellet of gray matter homogenates from AD cases
had an increase of V11.0 pmol phosphate/Wg protein. These
data indicated the presence of other abnormally hyperphos-
phorylated proteins in AD brain. Western blot analyses with
P-Ser antibodies revealed hyperphosphorylation of several
proteins. All detectable proteins, except a V54 kDa protein,
were also labeled with antibodies to tau, indicating hyper-
phosphorylation of a non-tau protein. We puri¢ed the V54
kDa protein by preparative SDS^PAGE. MS-MALDI analy-
Fig. 3. Puri¢cation of the V54 kDa protein and its identi¢cation as L-tubulin. The 100 000Ug pellet from AD brains was subjected to deter-
gent (1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS) extraction, followed by the extraction of the insoluble pellet with 6 M GnHCl.
The 6 M GnHCl extract was dialyzed against 50 mM Tris, pH 7.6, 2 M urea, 1 mM DTT, 50 mM NaF, 1 mM Na3VO4 and 1 mM PMSF,
and 1 mg of dialyzed protein was subjected to preparative SDS^PAGE. Protein fractions were collected and the V54 kDa protein-containing
fraction was identi¢ed on the basis of screening all the fractions by both Coomassie blue staining and Western blotting with P-Ser antibodies.
a: Coomassie blue staining of protein on a 10% SDS^PAGE. Lane 1 ^ GnHCl extract; lane 2 ^ puri¢ed V54 kDa protein-containing fraction.
b: Western blot with P-Ser antibody (1:750) or L-tubulin antibody (1:750). Lane 1 ^ GnHCl extract; lanes 2,3 ^ puri¢ed V54 kDa protein-
containing fraction from SDS^PAGE developed with antibodies to P-Ser (lane 2) or to L-tubulin (lane 3). c: MS-MALDI spectrum of Lys-C
peptides obtained from the puri¢ed V54 kDa protein. A total of 23 mass/charge (m/z) peaks were obtained. Upon matching with the data
bank, the V54 kDa protein was identi¢ed as L-tubulin. Abscissa: m/z ratio of the peptide fragments. Ordinate: Arbitrary units of intensity
(a.i). The table (right) lists the mass signals (1^23) attributed to Lys-C fragments of the V54 kDa protein with measured m/z values. d: N-ter-
minal amino acid sequence analysis of the V54 kDa protein puri¢ed by 10% preparative SDS^PAGE. The Coomassie-stained protein band
was excised from the gel and subjected to amino acid sequence analysis. The N-terminal sequence MREIVHIQAG obtained by this analysis
(upper panel) matched with that of L-tubulin (lower panel), con¢rming the identity. The results also revealed that the V54 kDa protein was
probably pure. Lower panel ^ the sequence of L-tubulin that identi¢ed with the V54 kDa protein by MS-MALDI analysis.
6
Fig. 4. Western blots of the preparative SDS^PAGE-puri¢ed V54
kDa protein developed with antibody to P-Ser. Preparative electro-
phoresis-puri¢ed V54 kDa protein from AD brain and from age-
matched control brains was electrophoresed on a 10% SDS^PAGE
and transferred to a polyvinylidene di£uoride membrane. After
blocking with 5% BSA^TBST, (a) phosphorylated serine residues
were immunodetected using polyclonal antibodies to P-Ser (1:750)
and (b) L-tubulin levels were immunodetected using monoclonal L-
tubulin antibody (1:750) followed by corresponding HRP-conju-
gated secondary antibody (1:25 000). P-Ser immunoreactivity nor-
malized against that of L-tubulin from blots as in (a) and (b) was
signi¢cantly (P6 0.05) higher in AD than in control brains (c). The
blots were developed by ECL reagents. The data in (c) is from three
AD and three control values.
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sis revealed the identity of the V54 kDa protein as L-tubulin
(X79535). We con¢rmed the identity of the puri¢ed protein by
Western blots developed with anti-L-tubulin antibodies, and
by amino-terminal amino acid sequencing. Amino-terminal
sequencing revealed that not only was the protein L-tubulin,
but also probably was pure. Western blots of the puri¢ed
protein developed with P-Ser and L-tubulin antibodies con-
¢rmed that L-tubulin from AD brains was indeed hyperphos-
phorylated as compared with that from control brains. Hyper-
phosphorylation of L-tubulin, a protein other than tau, in AD
brain is consistent with the hypothesis that a general imbal-
ance in the protein phosphorylation^dephosphorylation sys-
tem exists in the brains of AD patients. Other proteins which
have been shown to be hyperphosphorylated at serine/threo-
nine residues in AD brain include dynein [33], CRMP-2 [34]
and neuro¢lament heavy and medium subunits [35].
Tau is required for MT assembly, maintenance of MTs and
stability of MTs [36]. A large body of evidence has established
that hyperphosphorylated tau contributes to the MT disas-
sembly. It has been demonstrated that unlike normal tau,
AD P-tau cannot promote MT assembly, cannot stabilize
MT or maintain the MT structure [37^39]. AD P-tau seques-
ters normal tau, MAP1 and MAP2, and makes them unavail-
able for MT assembly [40]. But, the possible role of tubulin in
AD brain towards the disassembly of MTs has not been con-
sidered previously. A study has shown that bovine brain tu-
bulin when phosphorylated by a serine-threonine kinase, cal-
cium-calmodulin protein kinase, loses its ability to assemble
MTs and when dephosphorylated, tubulin regains its ability to
assemble MTs [41]. The activity of phosphoseryl/phospho-
threonyl PP-2A is decreased in AD brain [13,14] and an inhi-
bition of PP-2A activity in brain has been shown to result in
an increase in the activity of calcium-calmodulin-dependent
protein kinase II [15]. Phosphorylation has also been shown
to enhance the interaction of tubulin with the membrane [42].
Thus, hyperphosphorylation of L-tubulin in the 100 000Ug
particulate fraction might have resulted from the decrease in
PP-2A activity in AD brain.
The hyperphosphorylated L-tubulin observed by us might
be either from the membrane pool or cytoplasmic pool. If it is
from the cytoplasmic pool, which represent over 90% of total
brain tubulin, then only a small fraction of it might have
aggregated as a result of hyperphosphorylation into the par-
ticulate pool. L-Tubulin (X79535) is not a major isotype of L-
tubulin in neurons. L-III-Tubulin, which is the predominant
isotype in neurons, has been shown to be phosphorylated,
whereas type II and type IV were not found to be phosphor-
ylated [25]. Therefore, a slight decrease in the speci¢c isotype
(X79535) in the 100 000Ug supernatant may remain unde-
tected considering its relatively small contribution to this
pool. Although the contribution of L-tubulin (X79535) in
MT assembly in a young, healthy brain may not be very
signi¢cant, it might play a signi¢cant role in the AD brain
for the following reasons. In the brains of AD patients, nor-
mal tau is sequestered by AD P-tau which might result in a
decrease in available normal tau for MT assembly. Under
these conditions, even a small amount of hyperphosphory-
lated L-tubulin (presumably in a compromised functional
state) might contribute signi¢cantly to the disassembly of
MTs either directly or through tubulin^MAP interaction pro-
posed previously [25]. If the hyperphosphorylated L-tubulin
(X79535) belonged to the membrane pool, it would be hard
to attribute any function, since this area of research remains
unexplored.
Acknowledgements: We are grateful to Al Smith and Dick Winant of
Beckman Center, Stanford University, CA, USA, for MS and amino
acid sequencing. The secretarial assistance of Janet Biegelson and
Sonia Warren is gratefully acknowledged. Studies were supported in
part by the New York State O⁄ce of Mental Retardation and Devel-
opmental Disabilities, the Center for Developmental Neuroscience of
the City University of New York and by NIH Grants AG05892,
AG08076 and NS18105.
References
[1] Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.-C., Zaidi,
M.S. and Wisniewski, H.M. (1986) J. Biol. Chem. 261, 6084^
6089.
[2] Grundke-Iqbal, I., Iqbal, K., Tung, Y.-C., Quinlan, M., Wis-
niewski, H.M. and Binder, L.I. (1986) Proc. Natl. Acad. Sci.
USA 93, 4913^4917.
[3] Iqbal, K., Grundke-Iqbal, I., Zaidi, T., Merz, P.A., Wen, G.Y.,
Shaikh, S.S., Wisniewski, H.M., Alafuzo¡, I. and Winblad, B.
(1986) Lancet 2, 421^426.
[4] Iqbal, K., Grundke-Iqbal, I., Smith, A.J., George, L., Tung, Y.C.
and Zaidi, T. (1989) Proc. Natl. Acad. Sci. USA 86, 5646^5650.
[5] Lee, V.M.-Y., Balin, B.J., Otvos Jr., L. and Trojanowski, J.Q.
(1991) Science 251, 675^678.
[6] Liao, H., Li, Y., Brautigan, D.L. and Gundersen, G.G. (1998)
J. Biol. Chem. 273, 21901^21908.
[7] Sontag, E., Nunbhakdi-Craig, V., Lee, G., Brandt, R., Kami-
bayashi, C., Kuret, J., White 3rd, C.L., Mumby, M.C. and
Bloom, G.S. (1999) J. Biol. Chem. 274, 25490^25498.
[8] Pei, J.J., Sersen, E., Iqbal, K. and Grundke-Iqbal, I. (1994) Brain
Res. 655, 70^76.
[9] Tanaka, T., Zhong, J., Iqbal, K., Trenkner, E. and Grundke-
Iqbal, I. (1998) FEBS Lett. 426, 248^254.
[10] Gong, C.-X., Wegiel, J., Lidsky, T., Zuck, L., Avila, J., Wisniew-
ski, H.M., Grundke-Iqbal, I. and Iqbal, K. (2000) Brain Res.
853, 299^309.
[11] Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I.
and Iqbal, K. (2000) J. Biol. Chem 275, 5534^5544.
[12] Bennecib, M., Gong, C.-X., Grundke-Iqbal, I. and Iqbal, K.
(2000) FEBS Lett. 485, 87^93.
[13] Gong, C.-X., Singh, T.J., Grundke-Iqbal, I. and Iqbal, K. (1993)
J. Neurochem. 61, 921^927.
[14] Gong, C.-X., Shaikh, S., Wang, J.-Z., Zaidi, T., Grundke-Iqbal,
I. and Iqbal, K. (1995) J. Neurochem. 65, 732^738.
[15] Bennecib, M., Gong, C.-X., Grundke-Iqbal, I. and Iqbal, K.
(2001) FEBS Lett. 490, 15^22.
[17] Patricks, G.N., Zukerbergs, L., Nikolics, M., De la Montes, S.,
Dikkess, P. and Tsais, L.H. (1999) Nature 402, 615^622.
[18] Taniguchi, S., Fujita, Y., Hayashi, S., Kakita, A., Takahashi, H.,
Murayama, S., Saido, T.C., Hisanaga, S., Iwatsubo, T. and Ha-
segawa, M. (2001) FEBS Lett. 489, 46^50.
[19] Terry, R.D., Gonatas, N.K. and Weiss, M. (1964) Am. J. Pathol.
44, 269^297.
[20] Luduen‹a, R.F., Shooter, E.M. and Wilson, L. (1977) J. Biol.
Chem. 252, 7006^7014.
[21] Luduen‹a, R.F. (1993) Mol. Biol. Cell 4, 445^457.
[22] Eipper, B.A. (1972) Proc. Natl. Acad. Sci. USA 69, 2283^2287.
[23] Luduen‹a, R.F., Zimmerman, H.-P. and Little, M. (1988) FEBS
Lett. 230, 142^146.
[24] Diaz-Nido, J., Serrano, L., Lopez-Otin, C., Vanderkerckhove, J.
and Avila, J. (1990) J. Biol. Chem. 265, 13949^13954.
[25] Khan, I.A. and Luduen‹a, R.F. (1996) Biochemistry 34, 3704^
3711.
[26] Hess, H.H. and Derr, J.E. (1975) Anal. Biochem. 63, 607^613.
[27] Ko«pke, E., Tung, Y.-C., Shaikh, S., Alonso, A. del C., Iqbal, K.
and Grundke-Iqbal, I. (1993) J. Biol. Chem. 268, 24374^24383.
[28] Bensadoun, A. and Weinstein, D. (1976) Anal. Biochem. 70, 241^
250.
[29] Andersson, L. and Porath, J. (1986) Anal. Biochem. 154, 250^
254.
[30] Laemmli, U.K. (1970) Nature 227, 660^685.
FEBS 25587 10-12-01
S. Vijayan et al./FEBS Letters 507 (2001) 375^381380
[31] Khatoon, S., Grundke-Iqbal, I. and Iqbal, K. (1992) J. Neuro-
chem. 59, 750^753.
[32] Khatoon, S., Grundke-Iqbal, I. and Iqbal, K. (1994) FEBS Lett.
351, 80^84.
[33] Kopec, K. and Chambers, J.P. (1997) Proc. Soc. Exp. Biol. Med.
216, 429^437.
[34] Gu, Y., Hamajima, N. and Ihara, Y. (2000) Biochemistry 39,
4267^4275.
[35] Wang, J.-Z., Tung, Y.C., Wang, Y., Li, X.T., Iqbal, K. and
Grundke-Iqbal, I. (2001) FEBS Lett. 507, 81^87.
[36] Weingarten, M.D., Lockwood, A.H., Hwo, S.Y. and Kirschner,
M.W. (1975) Proc. Natl. Acad. Sci. USA 72, 1858^1862.
[37] Alonso, A., del, C., Zaidi, T., Grundke-Iqbal, I. and Iqbal, K.
(1994) Proc. Natl. Acad. Sci. USA 91, 5562^5566.
[38] Alonso, A., del, C., Grundke-Iqbal, I. and Iqbal, K. (1996) Nat.
Med. 2, 783^787.
[39] Iqbal, K., Zaidi, T., Bancher, C. and Grundke-Iqbal, I. (1994)
FEBS Lett. 349, 104^108.
[40] Alonso, A. del C., Grundke-Iqbal, I., Barra, H.S. and Iqbal, K.
(1997) Proc. Natl. Acad. Sci. USA 94, 298^303.
[41] Wandosell, F., Serrano, L., Hernandez, M.A. and Avila, J.
(1986) J. Biol. Chem. 261, 10332^10339.
[42] Hargreaves, A.J., Wandosell, F. and Avila, J. (1986) Nature 323,
827^828.
FEBS 25587 10-12-01
S. Vijayan et al./FEBS Letters 507 (2001) 375^381 381
